Also, the development of orally formulated GLP-1 drugs, usually administered via injection, is accelerating availability and patient compliance with enhanced convenience
SGLT2i use was associated with a significantly increased risk of DKA (RR 2.08 [95% CI 1.05, 4.12] p =0.0309)
It helps determine whether a patient is ready for a dose increase or if they should remain at their current level for a bit longer
With celebrity attention, positive clinical trials, and even more versions in the FDA approval pipeline, expect to see continued consumer demand
The FDA has been vocal about its concerns in this category
The Lactobacillus delbrueckii Surge : Fecal metagenomic sequencing unmasked that Lactobacillus delbrueckii was the single most significantly increased microbial species following liraglutide treatment